The Atypical Antipsychotic Drugs Market is expected to register a CAGR of 6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Atypical Antipsychotic Drugs Market report covers analysis by Drug Class (First Generation, Second Generation, Third Generation (Abilify)); Application (Bipolar Disorders, Schizophrenia, Dementia, Unipolar Depression, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) , and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Atypical Antipsychotic Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Atypical Antipsychotic Drugs Market Segmentation
Drug Class- First Generation
- Second Generation
- Third Generation
- Bipolar Disorders
- Schizophrenia
- Dementia
- Unipolar Depression
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Atypical Antipsychotic Drugs Market Growth Drivers- Increasing Prevalence of Mental Health Disorders:
The rising incidence of mental health disorders, such as schizophrenia, bipolar disorder, and major depressive disorder, is driving the demand for atypical antipsychotic drugs. These medications are commonly prescribed to manage symptoms associated with these conditions and offer better safety profiles than traditional antipsychotics.
- Growing Awareness of Mental Health and Treatment Options:
Increased awareness about mental health issues and the availability of effective treatment options is leading to more diagnoses and the subsequent demand for atypical antipsychotic drugs. Public and professional awareness campaigns contribute to improved diagnosis and treatment adherence.
- Favorable Side Effect Profile of Atypical Antipsychotics:
Atypical antipsychotic drugs generally have a lower risk of extrapyramidal side effects compared to traditional antipsychotics. This better side effect profile has contributed to their growing adoption in the treatment of various psychiatric conditions, especially in patients with long-term management needs.
- Emergence of Newer Atypical Antipsychotics:
Ongoing research and development are leading to the introduction of newer atypical antipsychotic drugs that provide more targeted treatment and improved side effect profiles. These innovations aim to offer more effective treatments with fewer risks of weight gain, sedation, and metabolic issues.
- Personalized Treatment Approaches:
The adoption of personalized medicine, including genetic testing and pharmacogenomics, is a key trend in the atypical antipsychotics market. Tailoring treatment based on individual genetic and metabolic profiles allows for better management of side effects and optimization of drug efficacy, contributing to better patient outcomes.
- Growing Use in Geriatric and Pediatric Populations:
The use of atypical antipsychotic drugs in elderly and pediatric populations is on the rise due to their efficacy in managing conditions like dementia-related agitation and pediatric bipolar disorder. Tailored formulations and dosages are helping to meet the unique needs of these age groups.
- Development of Combination Therapies:
There is an opportunity to develop combination therapies that integrate atypical antipsychotic drugs with other classes of medications, such as antidepressants or mood stabilizers. These combinations can offer comprehensive treatment options for complex psychiatric conditions like treatment-resistant schizophrenia or bipolar disorder.
- Telemedicine and Digital Health Platforms:
The growth of telemedicine and digital health platforms, particularly in mental health care, presents an opportunity for the atypical antipsychotic drugs market. Through remote consultations and digital health tools, patients can access medications more easily, leading to improved adherence and better management of their conditions.
- Focus on New Indications and Market Expansion:
The exploration of new indications for atypical antipsychotic drugs, such as in the treatment of major depression or anxiety disorders, offers significant growth potential. Expanding the clinical use of these drugs to new areas could drive demand and open new markets.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Atypical Antipsychotic Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Atypical Antipsychotic Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Key companies of this market are: Janssen Research and Development, LLC (Johnson and Johnson Services Inc), Eli Lilly and Company, Pfizer Inc., Bristol-Myers Squibb Company, Allergan plc, AstraZeneca plc, GlaxoSmithKline Plc., SANIS, Ranbaxy Pharmaceuticals Inc. (Sun Pharmaceutical Industries Ltd.), Teva Pharmaceutical Industries Ltd.
Key future trends in this market are - Rising Mental Health Cases, Safety Profile Improvements, Expanding into Emerging Markets
The Atypical Antipsychotic Drugs Market is estimated to witness a CAGR of 6% from 2023 to 2031.
The major factors driving the market are: Growing prevalence of mental health disorders, Shift toward safer treatment options, Regulatory approvals and market expansion
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Atypical Antipsychotic Drugs Market - By Drug Class
1.3.2 Atypical Antipsychotic Drugs Market - By Application
1.3.3 Atypical Antipsychotic Drugs Market - By Distribution Channel
1.3.4 Atypical Antipsychotic Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ATYPICAL ANTIPSYCHOTIC DRUGS - GLOBAL MARKET OVERVIEW
6.2. ATYPICAL ANTIPSYCHOTIC DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. FIRST GENERATION
7.3.1. Overview
7.3.2. First Generation Market Forecast and Analysis
7.3.3. Haldo Market
7.3.3.1. Overview
7.3.3.2. Haldo Market Forecast and Analysis
7.3.4. Navane Market
7.3.4.1. Overview
7.3.4.2. Navane Market Forecast and Analysis
7.3.5. Others Market
7.3.5.1. Overview
7.3.5.2. Others Market Forecast and Analysis
7.4. SECOND GENERATION
7.4.1. Overview
7.4.2. Second Generation Market Forecast and Analysis
7.4.3. Latuda Market
7.4.3.1. Overview
7.4.3.2. Latuda Market Forecast and Analysis
7.4.4. Invega Market
7.4.4.1. Overview
7.4.4.2. Invega Market Forecast and Analysis
7.4.5. Seroquel Market
7.4.5.1. Overview
7.4.5.2. Seroquel Market Forecast and Analysis
7.4.6. Risperdal Market
7.4.6.1. Overview
7.4.6.2. Risperdal Market Forecast and Analysis
7.4.7. Zyprexa Market
7.4.7.1. Overview
7.4.7.2. Zyprexa Market Forecast and Analysis
7.4.8. Geodon Market
7.4.8.1. Overview
7.4.8.2. Geodon Market Forecast and Analysis
7.4.9. Others Market
7.4.9.1. Overview
7.4.9.2. Others Market Forecast and Analysis
7.5. THIRD GENERATION (ABILIFY)
7.5.1. Overview
7.5.2. Third Generation (Abilify) Market Forecast and Analysis
8. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BIPOLAR DISORDERS
8.3.1. Overview
8.3.2. Bipolar Disorders Market Forecast and Analysis
8.4. SCHIZOPHRENIA
8.4.1. Overview
8.4.2. Schizophrenia Market Forecast and Analysis
8.5. DEMENTIA
8.5.1. Overview
8.5.2. Dementia Market Forecast and Analysis
8.6. UNIPOLAR DEPRESSION
8.6.1. Overview
8.6.2. Unipolar Depression Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Atypical Antipsychotic Drugs Market Overview
10.1.2 North America Atypical Antipsychotic Drugs Market Forecasts and Analysis
10.1.3 North America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
10.1.4 North America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Application
10.1.5 North America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Atypical Antipsychotic Drugs Market
10.1.6.1.1 United States Atypical Antipsychotic Drugs Market by Drug Class
10.1.6.1.2 United States Atypical Antipsychotic Drugs Market by Application
10.1.6.1.3 United States Atypical Antipsychotic Drugs Market by Distribution Channel
10.1.6.2 Canada Atypical Antipsychotic Drugs Market
10.1.6.2.1 Canada Atypical Antipsychotic Drugs Market by Drug Class
10.1.6.2.2 Canada Atypical Antipsychotic Drugs Market by Application
10.1.6.2.3 Canada Atypical Antipsychotic Drugs Market by Distribution Channel
10.1.6.3 Mexico Atypical Antipsychotic Drugs Market
10.1.6.3.1 Mexico Atypical Antipsychotic Drugs Market by Drug Class
10.1.6.3.2 Mexico Atypical Antipsychotic Drugs Market by Application
10.1.6.3.3 Mexico Atypical Antipsychotic Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Atypical Antipsychotic Drugs Market Overview
10.2.2 Europe Atypical Antipsychotic Drugs Market Forecasts and Analysis
10.2.3 Europe Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Application
10.2.5 Europe Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Atypical Antipsychotic Drugs Market
10.2.6.1.1 Germany Atypical Antipsychotic Drugs Market by Drug Class
10.2.6.1.2 Germany Atypical Antipsychotic Drugs Market by Application
10.2.6.1.3 Germany Atypical Antipsychotic Drugs Market by Distribution Channel
10.2.6.2 France Atypical Antipsychotic Drugs Market
10.2.6.2.1 France Atypical Antipsychotic Drugs Market by Drug Class
10.2.6.2.2 France Atypical Antipsychotic Drugs Market by Application
10.2.6.2.3 France Atypical Antipsychotic Drugs Market by Distribution Channel
10.2.6.3 Italy Atypical Antipsychotic Drugs Market
10.2.6.3.1 Italy Atypical Antipsychotic Drugs Market by Drug Class
10.2.6.3.2 Italy Atypical Antipsychotic Drugs Market by Application
10.2.6.3.3 Italy Atypical Antipsychotic Drugs Market by Distribution Channel
10.2.6.4 Spain Atypical Antipsychotic Drugs Market
10.2.6.4.1 Spain Atypical Antipsychotic Drugs Market by Drug Class
10.2.6.4.2 Spain Atypical Antipsychotic Drugs Market by Application
10.2.6.4.3 Spain Atypical Antipsychotic Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Atypical Antipsychotic Drugs Market
10.2.6.5.1 United Kingdom Atypical Antipsychotic Drugs Market by Drug Class
10.2.6.5.2 United Kingdom Atypical Antipsychotic Drugs Market by Application
10.2.6.5.3 United Kingdom Atypical Antipsychotic Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Atypical Antipsychotic Drugs Market Overview
10.3.2 Asia-Pacific Atypical Antipsychotic Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Atypical Antipsychotic Drugs Market
10.3.6.1.1 Australia Atypical Antipsychotic Drugs Market by Drug Class
10.3.6.1.2 Australia Atypical Antipsychotic Drugs Market by Application
10.3.6.1.3 Australia Atypical Antipsychotic Drugs Market by Distribution Channel
10.3.6.2 China Atypical Antipsychotic Drugs Market
10.3.6.2.1 China Atypical Antipsychotic Drugs Market by Drug Class
10.3.6.2.2 China Atypical Antipsychotic Drugs Market by Application
10.3.6.2.3 China Atypical Antipsychotic Drugs Market by Distribution Channel
10.3.6.3 India Atypical Antipsychotic Drugs Market
10.3.6.3.1 India Atypical Antipsychotic Drugs Market by Drug Class
10.3.6.3.2 India Atypical Antipsychotic Drugs Market by Application
10.3.6.3.3 India Atypical Antipsychotic Drugs Market by Distribution Channel
10.3.6.4 Japan Atypical Antipsychotic Drugs Market
10.3.6.4.1 Japan Atypical Antipsychotic Drugs Market by Drug Class
10.3.6.4.2 Japan Atypical Antipsychotic Drugs Market by Application
10.3.6.4.3 Japan Atypical Antipsychotic Drugs Market by Distribution Channel
10.3.6.5 South Korea Atypical Antipsychotic Drugs Market
10.3.6.5.1 South Korea Atypical Antipsychotic Drugs Market by Drug Class
10.3.6.5.2 South Korea Atypical Antipsychotic Drugs Market by Application
10.3.6.5.3 South Korea Atypical Antipsychotic Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Atypical Antipsychotic Drugs Market Overview
10.4.2 Middle East and Africa Atypical Antipsychotic Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Atypical Antipsychotic Drugs Market
10.4.6.1.1 South Africa Atypical Antipsychotic Drugs Market by Drug Class
10.4.6.1.2 South Africa Atypical Antipsychotic Drugs Market by Application
10.4.6.1.3 South Africa Atypical Antipsychotic Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Atypical Antipsychotic Drugs Market
10.4.6.2.1 Saudi Arabia Atypical Antipsychotic Drugs Market by Drug Class
10.4.6.2.2 Saudi Arabia Atypical Antipsychotic Drugs Market by Application
10.4.6.2.3 Saudi Arabia Atypical Antipsychotic Drugs Market by Distribution Channel
10.4.6.3 U.A.E Atypical Antipsychotic Drugs Market
10.4.6.3.1 U.A.E Atypical Antipsychotic Drugs Market by Drug Class
10.4.6.3.2 U.A.E Atypical Antipsychotic Drugs Market by Application
10.4.6.3.3 U.A.E Atypical Antipsychotic Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Atypical Antipsychotic Drugs Market Overview
10.5.2 South and Central America Atypical Antipsychotic Drugs Market Forecasts and Analysis
10.5.3 South and Central America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Application
10.5.5 South and Central America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Atypical Antipsychotic Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Atypical Antipsychotic Drugs Market
10.5.6.1.1 Brazil Atypical Antipsychotic Drugs Market by Drug Class
10.5.6.1.2 Brazil Atypical Antipsychotic Drugs Market by Application
10.5.6.1.3 Brazil Atypical Antipsychotic Drugs Market by Distribution Channel
10.5.6.2 Argentina Atypical Antipsychotic Drugs Market
10.5.6.2.1 Argentina Atypical Antipsychotic Drugs Market by Drug Class
10.5.6.2.2 Argentina Atypical Antipsychotic Drugs Market by Application
10.5.6.2.3 Argentina Atypical Antipsychotic Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ATYPICAL ANTIPSYCHOTIC DRUGS MARKET, KEY COMPANY PROFILES
12.1. JANSSEN RESEARCH AND DEVELOPMENT, LLC (JOHNSON AND JOHNSON SERVICES INC)
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ELI LILLY AND COMPANY
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOL-MYERS SQUIBB COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ALLERGAN PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA PLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANIS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. RANBAXY PHARMACEUTICALS INC. (SUN PHARMACEUTICAL INDUSTRIES LTD.)
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Janssen Research and Development, LLC (Johnson and Johnson Services Inc)
2. Eli Lilly and Company
3. Pfizer Inc.
4. Bristol-Myers Squibb Company
5. Allergan plc
6. AstraZeneca plc
7. GlaxoSmithKline Plc.
8. SANIS
9. Ranbaxy Pharmaceuticals Inc. (Sun Pharmaceutical Industries Ltd.)
10. Teva Pharmaceutical Industries Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For